Global Pressurized Metered Dose Inhaler Industry Growth and Trends Forecast to 2031

Summary

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

According to APO Research, The global Pressurized Metered Dose Inhaler market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Pressurized Metered Dose Inhaler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Pressurized Metered Dose Inhaler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Pressurized Metered Dose Inhaler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Pressurized Metered Dose Inhaler include GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, Teva, Merck & Co. Inc, Boehringer Ingelheim, Mylan and Arkon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pressurized Metered Dose Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pressurized Metered Dose Inhaler.

The Pressurized Metered Dose Inhaler market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pressurized Metered Dose Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Pressurized Metered Dose Inhaler Segment by Company

GlaxoSmithKline
Chiesi Farmaceutici S.p.A
AstraZeneca
Teva
Merck & Co. Inc
Boehringer Ingelheim
Mylan
Arkon

Pressurized Metered Dose Inhaler Segment by Type

Manual Pressurized Metered Dose Inhaler
Smart Pressurized Metered Dose Inhaler

Pressurized Metered Dose Inhaler Segment by Application

Asthma
COPD
Others

Pressurized Metered Dose Inhaler Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pressurized Metered Dose Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pressurized Metered Dose Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pressurized Metered Dose Inhaler.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pressurized Metered Dose Inhaler manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pressurized Metered Dose Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pressurized Metered Dose Inhaler Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Pressurized Metered Dose Inhaler Sales Estimates and Forecasts (2020-2031)
1.3 Pressurized Metered Dose Inhaler Market by Type
1.3.1 Manual Pressurized Metered Dose Inhaler
1.3.2 Smart Pressurized Metered Dose Inhaler
1.4 Global Pressurized Metered Dose Inhaler Market Size by Type
1.4.1 Global Pressurized Metered Dose Inhaler Market Size Overview by Type (2020-2031)
1.4.2 Global Pressurized Metered Dose Inhaler Historic Market Size Review by Type (2020-2025)
1.4.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Pressurized Metered Dose Inhaler Sales Breakdown by Type (2020-2025)
1.5.2 Europe Pressurized Metered Dose Inhaler Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Breakdown by Type (2020-2025)
1.5.4 South America Pressurized Metered Dose Inhaler Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Pressurized Metered Dose Inhaler Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Pressurized Metered Dose Inhaler Industry Trends
2.2 Pressurized Metered Dose Inhaler Industry Drivers
2.3 Pressurized Metered Dose Inhaler Industry Opportunities and Challenges
2.4 Pressurized Metered Dose Inhaler Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Pressurized Metered Dose Inhaler Revenue (2020-2025)
3.2 Global Top Players by Pressurized Metered Dose Inhaler Sales (2020-2025)
3.3 Global Top Players by Pressurized Metered Dose Inhaler Price (2020-2025)
3.4 Global Pressurized Metered Dose Inhaler Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Pressurized Metered Dose Inhaler Major Company Production Sites & Headquarters
3.6 Global Pressurized Metered Dose Inhaler Company, Product Type & Application
3.7 Global Pressurized Metered Dose Inhaler Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pressurized Metered Dose Inhaler Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pressurized Metered Dose Inhaler Players Market Share by Revenue in 2024
3.8.3 2023 Pressurized Metered Dose Inhaler Tier 1, Tier 2, and Tier 3
4 Pressurized Metered Dose Inhaler Regional Status and Outlook

4.1 Global Pressurized Metered Dose Inhaler Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Pressurized Metered Dose Inhaler Historic Market Size by Region
4.2.1 Global Pressurized Metered Dose Inhaler Sales in Volume by Region (2020-2025)
4.2.2 Global Pressurized Metered Dose Inhaler Sales in Value by Region (2020-2025)
4.2.3 Global Pressurized Metered Dose Inhaler Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Region
4.3.1 Global Pressurized Metered Dose Inhaler Sales in Volume by Region (2026-2031)
4.3.2 Global Pressurized Metered Dose Inhaler Sales in Value by Region (2026-2031)
4.3.3 Global Pressurized Metered Dose Inhaler Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Pressurized Metered Dose Inhaler by Application

5.1 Pressurized Metered Dose Inhaler Market by Application
5.1.1 Asthma
5.1.2 COPD
5.1.3 Others
5.2 Global Pressurized Metered Dose Inhaler Market Size by Application
5.2.1 Global Pressurized Metered Dose Inhaler Market Size Overview by Application (2020-2031)
5.2.2 Global Pressurized Metered Dose Inhaler Historic Market Size Review by Application (2020-2025)
5.2.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Pressurized Metered Dose Inhaler Sales Breakdown by Application (2020-2025)
5.3.2 Europe Pressurized Metered Dose Inhaler Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Breakdown by Application (2020-2025)
5.3.4 South America Pressurized Metered Dose Inhaler Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Pressurized Metered Dose Inhaler Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Comapny Information
6.1.2 GlaxoSmithKline Business Overview
6.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments
6.2 Chiesi Farmaceutici S.p.A
6.2.1 Chiesi Farmaceutici S.p.A Comapny Information
6.2.2 Chiesi Farmaceutici S.p.A Business Overview
6.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio
6.2.5 Chiesi Farmaceutici S.p.A Recent Developments
6.3 AstraZeneca
6.3.1 AstraZeneca Comapny Information
6.3.2 AstraZeneca Business Overview
6.3.3 AstraZeneca Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio
6.3.5 AstraZeneca Recent Developments
6.4 Teva
6.4.1 Teva Comapny Information
6.4.2 Teva Business Overview
6.4.3 Teva Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pressurized Metered Dose Inhaler Product Portfolio
6.4.5 Teva Recent Developments
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Comapny Information
6.5.2 Merck & Co. Inc Business Overview
6.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Comapny Information
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Mylan
6.7.1 Mylan Comapny Information
6.7.2 Mylan Business Overview
6.7.3 Mylan Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Pressurized Metered Dose Inhaler Product Portfolio
6.7.5 Mylan Recent Developments
6.8 Arkon
6.8.1 Arkon Comapny Information
6.8.2 Arkon Business Overview
6.8.3 Arkon Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Arkon Pressurized Metered Dose Inhaler Product Portfolio
6.8.5 Arkon Recent Developments
7 North America by Country

7.1 North America Pressurized Metered Dose Inhaler Sales by Country
7.1.1 North America Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Pressurized Metered Dose Inhaler Sales by Country (2020-2025)
7.1.3 North America Pressurized Metered Dose Inhaler Sales Forecast by Country (2026-2031)
7.2 North America Pressurized Metered Dose Inhaler Market Size by Country
7.2.1 North America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Pressurized Metered Dose Inhaler Market Size by Country (2020-2025)
7.2.3 North America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Pressurized Metered Dose Inhaler Sales by Country
8.1.1 Europe Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Pressurized Metered Dose Inhaler Sales by Country (2020-2025)
8.1.3 Europe Pressurized Metered Dose Inhaler Sales Forecast by Country (2026-2031)
8.2 Europe Pressurized Metered Dose Inhaler Market Size by Country
8.2.1 Europe Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Pressurized Metered Dose Inhaler Market Size by Country (2020-2025)
8.2.3 Europe Pressurized Metered Dose Inhaler Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country
9.1.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country (2020-2025)
9.1.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country
9.2.1 Asia-Pacific Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Pressurized Metered Dose Inhaler Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Pressurized Metered Dose Inhaler Sales by Country
10.1.1 South America Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Pressurized Metered Dose Inhaler Sales by Country (2020-2025)
10.1.3 South America Pressurized Metered Dose Inhaler Sales Forecast by Country (2026-2031)
10.2 South America Pressurized Metered Dose Inhaler Market Size by Country
10.2.1 South America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Pressurized Metered Dose Inhaler Market Size by Country (2020-2025)
10.2.3 South America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country
11.1.1 Middle East and Africa Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2020-2025)
11.1.3 Middle East and Africa Pressurized Metered Dose Inhaler Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country
11.2.1 Middle East and Africa Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Pressurized Metered Dose Inhaler Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Pressurized Metered Dose Inhaler Value Chain Analysis
12.1.1 Pressurized Metered Dose Inhaler Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pressurized Metered Dose Inhaler Production Mode & Process
12.2 Pressurized Metered Dose Inhaler Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pressurized Metered Dose Inhaler Distributors
12.2.3 Pressurized Metered Dose Inhaler Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings